• Physician Profile

    Scott A. Armstrong, MD, PhD

     
    Scott A. Armstrong, MD, PhD
     
    Chairman, Department of Pediatric Oncology
    Associate Chief, Division Hematology/Oncology, Boston Children's Hospital


    David G. Nathan Professor of Pediatrics, Harvard Medical School

    Center/Program

    Pediatric Hematologic Malignancies

    Office phone: 617-632-3644
    Appointment phone: 888-733-4662 (new); 617-632-3270 (established)
    Fax: 617-632-4367

    Preferred contact method: office phone
    Request an appointment

    View Researcher Profile
     
     

    Discipline

    Pediatric Hematology/Oncology

    Interest

    Hematologic malignancies


    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Boston, MA 02215

    Biography

    Scott A. Armstrong, MD, PhD, became the Chairman of the Department of Pediatric Oncology at Dana-Farber Cancer Institute in July 2016. He also serves as Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital.  He was previously the Director of the Center for Epigenetics Research at Memorial Sloan Kettering Cancer Center and Professor of Pediatrics at the Weill Cornell Medical College. Dr. Armstrong earned his medical degree and his PhD from University of Texas Southwestern Medical School in 1996. After internship and residency training with the Boston Combined Residency Program (BCRP) at Boston Medical Center and Boston Children’s Hospital, he completed a hematology/oncology fellowship at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. The major focus of his career has been on delineating the biology of childhood cancers and the development of new therapeutic approaches for children with cancer. His research program has focused on the mechanisms of leukemia development and the relationship between leukemia and normal hematopoietic stem cells.  He continues to direct a vigorous research program that focuses on development of new therapeutics that target chromatin based mechanisms, and he is actively involved in the development and translation of a number of new small molecule approaches that likely will be tested in clinical trials in the near future.

    Background

    Board Certification
    Pediatric Hematology/Oncology, 2002

    Fellowship
    Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 2001

    Residency
    Boston Combined Residency Program, Boston Children's Hospital/Boston Medical Center, Pediatrics, 1998

    Internship
    Boston Combined Residency Program, Boston Children's Hospital/Boston Medical Center, Pediatrics, 1998

    Medical School
    University of Texas Southwestern Medical School, 1996

View Researcher Directory
View Nurse Directory

Request an Appointment

  • For adults:
    877-442-3324 (877-442-DFCI)
  • For children:
    888-733-4662 (888-PEDI-ONC)
  • Or complete the online form.
 

How Our Patients Rate Dana-Farber